| Report ID |
19888 |
| Drug Identification Number |
02312557 |
| Brand name |
BOOSTRIX-POLIO |
| Common or Proper name |
Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
INACTIVATED POLIOVIRUS TYPE I
INACTIVATED POLIOVIRUS TYPE II
INACTIVATED POLIOVIRUS TYPE III
TETANUS TOXOID ADSORBED
DIPHTHERIA TOXOID ADSORBED
PERTUSSIS TOXOID ADSORBED
FILAMENTOUS HAEMAGGLUTININ ADSORBED
PERTACTIN ADSORBED |
| Strength(s) |
40D
8D
32D
5.0LF
2.5LF
8MCG
8MCG
2.5MCG |
| Dosage form(s) |
SUSPENSION |
| Route of administration |
INTRAMUSCULAR |
| Packaging size |
10's |
| ATC code |
J07CA |
| ATC description |
BACTERIAL AND VIRAL VACCINES, COMBINED |
| Reason for shortage |
Delay in shipping of the drug. |
| Anticipated start date |
|
| Actual start date |
2017-11-08 |
| Estimated end date |
2017-12-07 |
| Actual end date |
2017-12-06 |
| Shortage status |
Resolved |
| Updated date |
2017-12-07 |
| Company comments |
Supply released November 10, 2017 with limited quantity. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
